ImageneBio, Inc. (IMA)
NASDAQ: IMA · Real-Time Price · USD
5.00
-0.05 (-0.99%)
At close: Apr 2, 2026, 4:00 PM EDT
4.970
-0.030 (-0.60%)
After-hours: Apr 2, 2026, 4:00 PM EDT
ImageneBio Market Cap
ImageneBio has a market cap or net worth of $55.59 million as of April 2, 2026.
Market Cap
55.59M
Enterprise Value
-76.78M
1-Year Change
n/a
Ranking
Category
Stock Price
$5.00
Market Cap Chart
Since July 28, 2025, ImageneBio's market cap has decreased from $183.04M to $55.59M, a decrease of -69.63%. That is a compound annual growth rate of -82.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 55.59M | -27.95% |
| Dec 31, 2025 | 77.15M | -57.85% |
| Jul 28, 2025 | 183.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Acrivon Therapeutics | 58.89M |
| Actuate Therapeutics | 58.80M |
| Entera Bio | 58.74M |
| OnKure Therapeutics | 58.66M |
| ImmuCell | 58.26M |
| TScan Therapeutics | 57.47M |
| MindWalk Holdings | 57.36M |
| Instil Bio | 54.66M |